Alchemy Investments delays Q1 2026 Form 10-Q

Rhea-AI Filing Summary

Alchemy Investments Acquisition Corp 1 notified the SEC that it cannot file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense."

The company states it is working diligently and expects to file the Quarterly Report within five calendar days of the prescribed due date. The notification is signed by CEO Mattia Tomba and the filing includes SEC file number 001-41139.

Insights

Compliance Officer

Routine late-filing notice under Rule 12b-25; company expects short delay.

The filing is a Rule 12b-25 notification stating the registrant cannot file its Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense." The company expects to file within five calendar days of the prescribed due date.

Materiality depends on disclosed results; the company explicitly states no significant change in results is anticipated. Subsequent filings will confirm whether earnings or disclosures change the picture.

Financial Reporting Analyst

This is an administrative extension notice, not an earnings disclosure.

The notice documents an inability to meet the Form 10-Q deadline and invokes Rule 12b-25(b) language: "without unreasonable effort or expense." It identifies the period ended March 31, 2026 and an expected five-calendar-day delay.

Key items to watch are the eventual Form 10-Q contents and whether the company amends its statement about anticipated results; timing and the filed report will determine investor impact.

Key Figures

Period Ended: March 31, 2026 Expected Filing Delay: 5 calendar days SEC File Number: 001-41139 +3 more

6 metrics

Period Ended March 31, 2026 Quarterly Report period end

Expected Filing Delay 5 calendar days Expected time to file after the prescribed due date

SEC File Number 001-41139 Filing identifier on the notification

CUSIP 123013104 Security identifier listed on the cover

Contact Phone 212-877-1588 Telephone number provided for contact

Signature Date May 18, 2026 Date the notification was signed by CEO

Key Terms

Rule 12b-25, Form 10-Q, prescribed due date, SEC file number

4 terms

Rule 12b-25 regulatory

""without unreasonable effort or expense""

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-Q regulatory

"Quarterly Report on Form 10-Q for the period ended March 31, 2026"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

prescribed due date regulatory

"file the Quarterly Report by the prescribed due date"

SEC file number regulatory

"SEC FILE NUMBER 001-41139"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Alchemy Investments Acquisition Corp 1 file an NT 10-Q?

The company filed NT 10-Q because it cannot meet the Form 10-Q deadline "without unreasonable effort or expense." It notifies the SEC for the Quarterly Report covering the period ended March 31, 2026 and outlines an expected short delay.

When does ALCY expect to file the delayed Form 10-Q?

Alchemy expects to file the Quarterly Report within five calendar days of the prescribed due date. The notification states the company is working diligently to complete and submit the Form 10-Q promptly.

Does the NT 10-Q say results will change materially for the quarter?

No. The company answered "No" when asked if a significant change in results of operations is anticipated compared with the prior year period. That response suggests no material change is expected in disclosed earnings.

Who signed the late-filing notice for Alchemy Investments Acquisition Corp 1?

The notice was signed by Mattia Tomba, Chief Executive Officer. The document lists contact information and the signature date of May 18, 2026 on the notification.

What identifiers appear on the NT 10-Q filing for ALCY?

The filing includes SEC file number 001-41139 and CUSIP 123013104. These identifiers appear on the Rule 12b-25 notification cover information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 12:18 PM Learn about SEC filing dates

	UNITED STATES	OMB APPROVAL
	SECURITIES AND EXCHANGE COMMISSION	OMB Number:	3235-0058
	Washington, D.C. 20549	Expires:	April 30, 2025
		Estimated average burden
	FORM 12b-25	hours per response	2.50
	NOTIFICATION OF LATE FILING	SEC FILE NUMBER
		001-41139
		CUSIP NUMBER
		123013104

(Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR

	For Period Ended: March 31, 2026
	¨	Transition Report on Form 10-K
	¨	Transition Report on Form 20-F
	¨	Transition Report on Form 11-K
	¨	Transition Report on Form 10-Q
	For the Transition Period Ended: _______________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

Alchemy Investments Acquisition Corp 1

Full Name of Registrant

Former Name if Applicable

850 Library Avenue, Suite 204-F

Address of Principal Executive Office (Street and Number)

Newark, DE 19711

City, State and Zip Code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
x	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 10-Q, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III – NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

ALCHEMY INVESTMENTS ACQUISITION CORP 1. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) by the prescribed due date.

The Company is working diligently to file the Quarterly Report as soon as practicable and expects to file the Quarterly Report within five calendar days of the prescribed due date.

(Attach extra Sheets if Needed)

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

	Mattia Tomba		212		877-1588
	(Name)		(Area Code)		(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
		Yes x No¨
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
		Yes ¨ Nox

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Alchemy Investments Acquisition Corp 1
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date	May 18, 2026		By	/s/ Mattia Tomba
				Mattia Tomba
				Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).